The introduction of GLP-1 agonists and SGLT-2 inhibitors offers a promising therapeutic option
Early research into the physiological functions of GLP-1 revealed its critical role in glucose metabolism, leading to its therapeutic potential in treating diabetes and obesity
Dose escalation may be appropriate if you've been on a submaximal dose (below 15 mg weekly) for at least four weeks and have tolerated it well
Lilly will provide $200 million in funding to Pharmaron to support manufacturing preparation for Orforglipron, Lillys upcoming oral GLP-1 drug candidate
[11] In a randomized controlled trial (RCT) comparing liraglutide, glargine, glimepiride, and sitagliptin (all added to metformin) with a follow-up of five years, glargine and liraglutide were modestly more effective in achieving and maintaining target HbA1c, [20] with no difference in outcomes of microvascular and cardiovascular disease
This send a message that the stomach is full